Prediabetes Common Among Adult Survivors of Childhood Cancer

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 22, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 22, 2023 -- Prediabetes is highly prevalent in adult survivors of childhood cancer and is associated with future cardiovascular and kidney complications, according to a study published online Dec. 13 in the Journal of Clinical Oncology.

Stephanie B. Dixon, M.D., M.P.H., from St. Jude Children's Research Hospital in Memphis, Tennessee, and colleagues examined rates of prediabetes and the associated risk for cardiovascular events and chronic kidney disease (CKD) in adult survivors of childhood cancer. The analysis included 3,529 adults at least five years from childhood cancer diagnosis and 448 controls.

The researchers found that among survivors, the prevalence of prediabetes was 29.2 versus 18.1 percent in controls, and the prevalence of diabetes was 6.5 versus 4.7 percent, respectively. Among survivors aged 40 to 49 years, more than half of the survivors had prediabetes (45.5 percent) or diabetes (14.0 percent). Compared with survivors with normal glucose control, those with prediabetes had an increased risk for subsequent myocardial infarction (hazard ratio [HR], 2.4) and CKD (HR, 2.9), while those with diabetes also had a heighted risk for future cardiomyopathy (HR, 3.8) and stroke (HR, 3.4) when adjusting for previous cancer treatment.

"We need to help survivors understand that prediabetes is really an early warning sign that says you need to do something, whether that’s changing lifestyle, starting medication, or following up with primary care," Dixon said in a statement.

Several authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-23 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords